These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14979908)

  • 41. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
    Huang LX; Hu CY; Jing L; Wang MC; Xu M; Wang J; Wang Y; Nan KJ; Wang SH
    Cancer Sci; 2017 Oct; 108(10):1985-1995. PubMed ID: 28771881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kallistatin suppresses cancer development by multi-factorial actions.
    Chao J; Li P; Chao L
    Crit Rev Oncol Hematol; 2017 May; 113():71-78. PubMed ID: 28427524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association among the expression of β-catenin, cyclin D1 and estrogen receptor-β in human breast cancer.
    Guo L; Yilamu D; Sun L; Liu S; Ma F
    Exp Ther Med; 2015 Oct; 10(4):1423-1428. PubMed ID: 26622501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6.
    Zhang J; Yang Z; Li P; Bledsoe G; Chao L; Chao J
    Mol Cell Biochem; 2013 Jul; 379(1-2):295-301. PubMed ID: 23666756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells.
    Guturi KK; Mandal T; Chatterjee A; Sarkar M; Bhattacharya S; Chatterjee U; Ghosh MK
    J Biol Chem; 2012 May; 287(22):18287-96. PubMed ID: 22493441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Convergence between Wnt-β-catenin and EGFR signaling in cancer.
    Hu T; Li C
    Mol Cancer; 2010 Sep; 9():236. PubMed ID: 20828404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant expression of a beta-catenin gain-of-function mutant induces hyperplastic transformation in the mouse cornea.
    Zhang Y; Call MK; Yeh LK; Liu H; Kochel T; Wang IJ; Chu PH; Taketo MM; Jester JV; Kao WW; Liu CY
    J Cell Sci; 2010 Apr; 123(Pt 8):1285-94. PubMed ID: 20332116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts.
    Chen S; McLean S; Carter DE; Leask A
    J Cell Commun Signal; 2007 Dec; 1(3-4):175-83. PubMed ID: 18600477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptome analysis identifies pathways associated with enhanced maternal performance in QSi5 mice.
    Ramanathan P; Martin IC; Gardiner-Garden M; Thomson PC; Taylor RM; Ormandy CJ; Moran C; Williamson P
    BMC Genomics; 2008 Apr; 9():197. PubMed ID: 18442417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
    Schiff R; Massarweh SA; Shou J; Bharwani L; Arpino G; Rimawi M; Osborne CK
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():10-20. PubMed ID: 16273359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
    Musgrove EA
    Breast Cancer Res; 2004; 6(2):65-8. PubMed ID: 14979908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidermal growth factor receptor-directed enterocyte proliferation does not induce Wnt pathway transcription.
    Taylor JA; Bernabe KQ; Guo J; Warner BW
    J Pediatr Surg; 2007 Jun; 42(6):981-6. PubMed ID: 17560206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.